Bimekizumab Antibody
Bimekizumab is a humanized monoclonal antibody that simultaneously neutralizes IL-17A and IL-17F. It is a valuable research tool for studying psoriatic and arthritic disease mechanisms, supporting both in vitro assays of cytokine blockade and in vivo models of inflammation and bone biology.
Product Specifications
Product Name Alternative
THPTA
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
3.59 mg/mL
Purity
>95.0% (May vary between batches)
Molecular Weight
147.24 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog